M&A activity is going beyond big pharma acquisitions with Supernus Pharmaceuticals and Indivior Pharmaceuticals reaching a ...

An Elevance Health Public Policy Institute study found rural patients used telehealth less than non-rural patients across all ...

The products that succeed over time are usually the ones that make life easier, fit naturally into existing routines and ...

How can a biotech startup raise more than $1 billion over four plus years and say almost nothing publicly along the way? For Treeline Biosciences, the silence was strategic. Out of view of prying eyes ...

Eli Lilly metabolic disorder medication tirzepatide, already approved in type 2 diabetes and weight management, now has early clinical data indicating it can also help patients with a fatty liver ...

The FTC and the states of Utah and California sued Hims & Hers, alleging it improperly shared consumers’ health information ...

Aldeyra Therapeutics’ drug for dry eye disease has been rejected by the FDA, marking the third time in three years the eye drop has failed to clear the agency’s regulatory bar. The FDA decision also ...

Providence announced this week that it wants to sell its health plan, signaling its desire to exit the “payvider” club. Being a payvider — an organization that both provides healthcare services and ...

Assured Health raised $19 million for its AI agents that verify provider credentials and manage insurance enrollment for ...

Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.58 billion. The deal puts J&J in the mix ...

Hope is a catalyst for scientific ambition. It encourages researchers, clinicians, investors, and innovators to pursue ...

With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product ...